Results 71 to 80 of about 2,077 (188)

Endometrial assessment in abnormal uterine bleeding: transvaginal ultrasound alone may not be good enough

Ultrasound in Obstetrics &Gynecology, Volume 67, Issue 1, Page 79-88, January 2026.
ABSTRACT Objective To evaluate the proportion of optimal assessments of endometrial thickness (ET) achieved by transvaginal ultrasound (TVS) compared with a multimodal (MM) sonographic approach in women with abnormal uterine bleeding (AUB). Methods This prospective observational study was a subset of the EPI‐SURE study conducted between June and ...
S. Nijjar, S. Kastora, A. Bajrami, S. Solangon, M. Widschwendter, D. Jurkovic   +5 more
wiley   +1 more source

Non-invasive treatment of vulvovaginal atrophy in menopause with CO2 laser

, 2021
Genitourinary syndrome of menopause (GSM) may affect up to 90% of menopausal women, including vulvovaginal atrophy (VVA), burning, pain, bleeding, irritation, dyspareunia, anorgasmia, and urinary symptoms. Vaginal symptoms from lack of estrogens can have
Scudo, Maria, Perniola, Giorgia, Palaia, Innocenza, Logoteta, Alessandra, Monti, Marco, Di Donato, Violante, Benedetti Panici, Pierluigi, Cascialli, Gianluca, Muzii, Ludovico, Prata, Giovanni, Mondo, Alessandro, D'oria, Ottavia, Giannini, Andrea   +12 more
core   +1 more source

Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial [PDF]

, 2020
Objective: To assess the efficacy and safety of ultra-low dose 0.005% estriol vaginal gel in women with breast cancer receiving nonsteroidal aromatase inhibitors (NSAIs) and experiencing treatment-related vulvovaginal symptoms and signs.
Miriam Campos-Delgado, Miguel Gil-Gil, Lidbrink, E, Angelica Lindén Hirschberg, Pedro Sánchez-Rovira, Nieto-Magro, Concepción, Presa Lorite, Jesús, Hirschberg, Angelica Lindén, Jesús Presa-Lorite, Campos-Delgado, M, Sánchez-Rovira, Pedro, Javier Suárez-Almarza, Lidbrink, Elisabet, Suárez Almarza, Javier, Presa-Lorite, Jesús, Gil-Gil, Miguel, Nieto-Magro, C, Suárez-Almarza, Javier, Campos-Delgado, Miriam, Elisabet Lidbrink, Sanchez-Rovira, P, Hirschberg, AL, Lindén Hirschberg, Angelica, Gil Gil, Miguel, Campos Delgado, Míriam, Nieto Magro, Concepción, Presa-Lorite, J, Sánchez Rovira, Pedro, Concepción Nieto-Magro, Gil-Gil, M, Suarez-Almarza, J   +30 more
core   +1 more source

Antifungal Nanoparticles in Microbial Biotechnology: Multisector Mechanisms, Applications, and Future Frontiers

IET Nanobiotechnology, Volume 2026, Issue 1, 2026.
Fungal pathogens threaten global food security, ecosystem stability, and human health, while the overuse of conventional fungicides accelerates resistance and disrupts beneficial microbiota. Nanotechnology offers a powerful new paradigm for fungal control, but its greatest potential lies at the interface with microbial biotechnology.
Kaveh Rahimi Mamaghani, Marzieh Alikarami, Hossein Saremi, Nader Parvin, Jing Tu   +4 more
wiley   +1 more source

Ospemifene efficacy and safety data in women with vulvovaginal atrophy

Gynecological Endocrinology, 2020
Vulvovaginal atrophy (VVA) is a frequent, underreported and underdiagnosed condition. Ospemifene is a third-generation Selective Estrogen Receptor Modulator (SERM) that has been shown to be effective in women with VVA and dyspareunia, vaginal dryness and vulvar vestibular symptoms.
Lino Del, Pup, Rafael, Sánchez-Borrego
openaire   +2 more sources

Fractional CO2 laser treatment for vulvovaginal atrophy symptoms and vaginal rejuvenation in perimenopausal women

, 2017
César Arroyo HM Montepríncipe University Hospital Laser Unit, Madrid, Spain Background: This study investigated a novel fractional carbon dioxide (CO2) laser for treatment of symptoms associated with vulvovaginal atrophy (VVA) in ...
Arroyo C
core  

The European Vulvovaginal Epidemiological Survey (EVES). Impact of history of breast cancer on prevalence, symptoms, sexual function and quality of life related to vulvovaginal atrophy

, 2020
Objective: Women with history of breast cancer (HBC) frequently suffer from vulvovaginal atrophy (VVA). European Vulvovaginal Epidemiology Survey (EVES) sub-analysis assesses the impact of HBC on VVA, sexual life and quality of life (QoL) in ...
Panay N., Palacios S., Particco M., Nappi R. E., Bruyniks N.   +4 more
core   +1 more source

The European Vulvovaginal Epidemiological Survey (EVES) in Italy. Impact of vulvovaginal atrophy on the quality of life and sexual function in breast cancer survivors

, 2021
The European Vulvovaginal Epidemiology Survey (EVES) sub-analysis assesses the impact of history of breast cancer (HBC) on vulvovaginal atrophy (VVA), sexual function and quality of life in a sample of postmenopausal women. Women aged 45-75 years with at
Becorpi A. M., Palacios S., de Seta F., Surico N., Cicinelli E., Paoletti A. M., Guida M., Pellegrino A., Benedetti Panici P., Marchesoni D., Benedetto C., Luisi S., Paolantonio T. D., Cagnacci A., Busacca M., Remorgida V., Di Carlo C., Villa P., Cianci A., Salvatore S., Gambacciani M., Nappi R. E., Biglia N., Seracchioli R., Stomati M.   +24 more
core   +1 more source

Effective correction of genitourinary menopausal syndrome by the method of fractional laser ablation [PDF]

РМЖ. Мать и дитя, 2018
Effective correction of genitourinary menopausal syndrome by the method of fractional laser ablation Dobrokhotova Yu.E., Ilyina I.Yu., Venediktova M.G., Utina M.S., Morozova K.V., Suvorova V.A., Vasilyeva A.S.
Yu.E. Dobrokhotova, Ilina I.Yu., Venediktova M.G., Utina M.S., Morozova K.V., Suvorova V.A., Vasilyeva A.S.   +6 more
doaj  

The European Vulvovaginal Epidemiological Survey (EVES): impact on sexual function of vulvovaginal atrophy of menopause

, 2020
OBJECTIVE: To estimate the impact of vulvovaginal atrophy (VVA) on sexual function in a clinical population of postmenopausal women. METHODS: Women 45 to 75 years old and more than 12 months after the last menstruation, who attended menopausal ...
Panay N., Palacios S., Particco M., Nappi R. E., Djumaeva S.   +4 more
core   +1 more source